| Notes to the financial statements | Note 5 |
|
| COMPANY |
|
|
|
GROUP |
|
| 2016 |
|
|
2015
Restated^ |
|
|
(R’million) |
2016 |
|
|
2015
Restated#^ |
|
| |
|
|
|
|
5 |
Impairments |
|
|
|
|
|
| – |
|
|
– |
|
|
Impairment of property, plant and equipment (refer note 15) |
(34,8) |
|
|
(39,8) |
|
| – |
|
|
(678,8) |
|
|
Impairment of intangible assets/investments (refer note 15) |
(300,0) |
|
|
(280,0) |
|
| – |
|
|
(678,8) |
|
|
|
(334,8) |
|
|
(319,8) |
|
| # |
Restated as required by IFRS 5 in relation to the treatment of Tiger Branded Consumer Goods plc (TBCG) as a discontinued operation. |
| ^ |
Historically, impairments have been disclosed as part of total abnormal items on the face of the income statement with a supporting note
specifying the respective detail. For better clarity, impairments are now disclosed separately on the face of the income statement, with the
comparative information being restated accordingly. |
| Notes to the financial statements | Note 5 |
|
|